NCT00039832View on ClinicalTrials.gov

ReoPro and Retavase to Restore Brain Blood Flow After Stroke

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

April 30, 2007

Study Completion Date

May 31, 2008

Conditions
Cerebrovascular Accident
Interventions
DRUG

Abciximab (ReoPro) and Reteplase (Retavase)

Trial Locations (4)

20010

Washington Hospital Center, Washington D.C.

20814

Suburban Hospital, Bethesda

Unknown

Washington Adventist Hospital, Takoma Park

Ruprecht Karl Heidelberg Hospital, Heidelberg

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00039832 - ReoPro and Retavase to Restore Brain Blood Flow After Stroke | Biotech Hunter | Biotech Hunter